Osteoporosis – Pipeline Review, H2 by Gosreports 2020

1
Global Automotive Relay Market Research Report
2016
2
Osteoporosis Pipeline Review, H2 by Gosreports
2020 Global Markets Directs latest
Pharmaceutical and Healthcare disease pipeline
guide Osteoporosis Pipeline Review, H2 2016,
provides an overview of the Osteoporosis
(Metabolic Disorders) pipeline landscape. Osteopo
rosis, or thinning bones, makes bones weak and
more likely to break. Risk factors for
osteoporosis include aging, being female, low
body weight, low sex hormones or menopause,
smoking, and some medications. Signs and symptoms
include back pain, caused by a fractured or
collapsed vertebra, loss of height over time, a
stooped posture, a bone fracture that occurs much
more easily than expected. Prevention and
treatment include calcium and vitamin D,
exercise, and osteoporosis medications. Request
for sample of this research report http//www.gos
reports.com/osteoporosis-pipeline-review-h2-2016/

3
Some points from TOC Part I Automotive Relay
Overview Table of Contents Table of Contents
2 Introduction 6 Osteoporosis Overview
7 Therapeutics Development 8 Osteoporosis
Therapeutics under Development by Companies
10 Osteoporosis Therapeutics under
Investigation by Universities/Institutes
15 Osteoporosis Pipeline Products Glance
16 Osteoporosis Products under Development by
Companies 19 Osteoporosis Products under
Investigation by Universities/Institutes
25 Osteoporosis Companies Involved in
Therapeutics Development 26 Osteoporosis
Therapeutics Assessment 90 Drug Profiles
102 Osteoporosis Dormant Projects
253 Osteoporosis Discontinued Products
265 Osteoporosis Product Development Milestones
267 Appendix 282? List of Tables Number of
Products under Development for Osteoporosis, H2
2016 21
4
Some points from TOC Comparative Analysis by
Late Stage Development, H2 2016 29 Comparative
Analysis by Clinical Stage Development, H2 2016
30 Comparative Analysis by Early Stage
Development, H2 2016 31 Products under
Development by Companies, H2 2016 32 Products
under Development by Companies, H2 2016
(Contd..1) 33 Products under Development by
Companies, H2 2016 (Contd..2) 34 Products under
Development by Companies, H2 2016 (Contd..3)
35 Products under Development by Companies, H2
2016 (Contd..4) 36 Products under Development by
Companies, H2 2016 (Contd..5) 37 Products under
Investigation by Universities/Institutes, H2 2016
38 Osteoporosis Pipeline by Addex Therapeutics
Ltd, H2 2016 39 Osteoporosis Pipeline by
Alethia Biotherapeutics Inc., H2 2016
40 Osteoporosis Pipeline by Alize Pharma SAS,
H2 2016 41 Osteoporosis Pipeline by Alkem
Laboratories Ltd., H2 2016 42 Osteoporosis
Pipeline by AlphaMab Co., Ltd, H2 2016
43 Osteoporosis Pipeline by Alvogen Korea Co.,
Ltd., H2 2016 44 Osteoporosis Pipeline by Amgen
Inc., H2 2016 45 Osteoporosis Pipeline by Amura
Holdings Limited, H2 2016 46
5
Osteoporosis Pipeline by Cellmid Limited, H2
2016 51 Osteoporosis Pipeline by Chronos
Therapeutics Limited, H2 2016 52 Osteoporosis
Pipeline by Chugai Pharmaceutical Co., Ltd., H2
2016 53 Osteoporosis Pipeline by Corium
International, Inc., H2 2016 54 Osteoporosis
Pipeline by Critical Pharmaceuticals Limited, H2
2016 55 Osteoporosis Pipeline by Daiichi Sankyo
Company, Limited, H2 2016 56 Osteoporosis
Pipeline by ElexoPharm GmbH, H2 2016
57 Osteoporosis Pipeline by Eli Lilly and
Company, H2 2016 58 Osteoporosis Pipeline by
EndoCeutics, Inc., H2 2016 59 Osteoporosis
Pipeline by Enteris BioPharma, Inc., H2 2016
60 Osteoporosis Pipeline by Enzo Biochem, Inc.,
H2 2016 61 Osteoporosis Pipeline by Gador S.A.,
H2 2016 62 Osteoporosis Pipeline by Galapagos
NV, H2 2016 63 Osteoporosis Pipeline by Glide
Pharmaceutical Technologies Limited, H2 2016
64 Osteoporosis Pipeline by Hanmi
Pharmaceuticals, Co. Ltd., H2 2016
65 Osteoporosis Pipeline by Haoma Medica Ltd.,
H2 2016 66 Osteoporosis Pipeline by Immunovo
BV, H2 2016 67 Osteoporosis Pipeline by Intas
Pharmaceuticals Ltd., H2 2016 68 Osteoporosis
Pipeline by Ipsen S.A., H2 2016 69 Osteoporosis
Pipeline by Kaken Pharmaceutical Co., Ltd., H2
2016 70 Osteoporosis Pipeline by Lead Discovery
Center GmbH, H2 2016 71 Osteoporosis Pipeline
by Ligand Pharmaceuticals, Inc., H2 2016 72
6
Osteoporosis Pipeline by Merck Co., Inc., H2
2016 73 Osteoporosis Pipeline by Mereo
Biopharma Group Plc, H2 2016 74 Osteoporosis
Pipeline by Midway Pharmaceuticals, Inc., H2 2016
75 Osteoporosis Pipeline by Mithra
Pharmaceuticals S.A., H2 2016 76 Osteoporosis
Pipeline by NIBEC, H2 2016 77 Osteoporosis
Pipeline by Novartis AG, H2 2016 78 Osteoporosis
Pipeline by Omeros Corporation, H2 2016
79 Osteoporosis Pipeline by Oncobiologics,
Inc., H2 2016 80 Osteoporosis Pipeline by
Oscotec Inc., H2 2016 81 Osteoporosis Pipeline
by OsteoGeneX Inc., H2 2016 82 Osteoporosis
Pipeline by Osteologix Holdings Plc., H2 2016
83 Osteoporosis Pipeline by Paras
Biopharmaceuticals Finland Oy, H2 2016
84 Osteoporosis Pipeline by Pfenex Inc., H2
2016 85 Osteoporosis Pipeline by PhytoHealth
Corporation, H2 2016 86 Osteoporosis Pipeline
by R-Pharm, H2 2016 87 Osteoporosis Pipeline by
Recursion Pharmaceuticals, LLC, H2 2016
88 Osteoporosis Pipeline by Ribomic Inc., H2
2016 89 Osteoporosis Pipeline by Shanghai
Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., H2
2016 90 Osteoporosis Pipeline by Shin Poong
Pharm.Co., Ltd., H2 2016 91 Osteoporosis
Pipeline by Sinil Pharmaceutical Co., Ltd, H2
2016 92 ..........................................
...
7
More related reports http//www.gosreports.com/os
teoporosis-pipeline-review-h2-2016/ About
GosreportsGos International Inc. is one of the
leading distributors of market research reports
in the world today. We host more than 40,000
research products from the worlds top
publication houses.Our web-based platform offers
an unmatched collection of market research
reports, company reviews, databooks, articles,
periodical publications, databases, and much
more, delivered by the successful and
well-established publishers with whom we are
currently in partnership.Contacts UsJoanna
Executive - International Business and partner
RelationsE-mail info_at_gosreports.com Tel
001-510-400-8520Web http//www.gosreports.com